Studies using inducible APP mouse models of AD are congruent with these observations, because APP expression and Aβ production are suppressed upon removal of the inducer doxycyline, but the mice retain a considerable Aβ load for the following six months [27], [28]. This evidence concerns the gene APP and Alzheimer disease.